SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-23-043299
Filing Date
2023-05-26
Accepted
2023-05-26 07:01:01
Documents
13
Period of Report
2023-02-09
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM 8-K ea179300-8ka2_avalon.htm   iXBRL 8-K/A 44562
2 UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION FOR THE COMPANY, AS OF AN ea179300ex99-2_avalon.htm EX-99.2 199204
  Complete submission text file 0001213900-23-043299.txt   436638

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE albt-20230209.xsd EX-101.SCH 3251
4 XBRL LABEL FILE albt-20230209_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE albt-20230209_pre.xml EX-101.PRE 22375
7 EXTRACTED XBRL INSTANCE DOCUMENT ea179300-8ka2_avalon_htm.xml XML 3984
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38728 | Film No.: 23963014
SIC: 2836 Biological Products, (No Diagnostic Substances)